Document Detail


Infliximab prevents increased systolic blood pressure and upregulates the AKT/eNOS pathway in the aorta of spontaneously hypertensive rats.
MedLine Citation:
PMID:  23220708     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
High systolic blood pressure caused by endothelial dysfunction is a comorbidity of metabolic syndrome that is mediated by local inflammatory signals. Insulin-induced vasorelaxation due to endothelial nitric oxide synthase (eNOS) activation is highly dependent on the activation of the upstream insulin-stimulated serine/threonine kinase (AKT) and is severely impaired in obese, hypertensive rodents and humans. Neutralisation of circulating tumor necrosis factor-α (TNFα) with infliximab improves glucose homeostasis, but the consequences of this pharmacological strategy on systolic blood pressure and eNOS activation are unknown. To address this issue, we assessed the temporal changes in the systolic pressure of spontaneously hypertensive rats (SHR) treated with infliximab. We also assessed the activation of critical proteins that mediate insulin activity and TNFα-mediated insulin resistance in the aorta and cardiac left ventricle. Our data demonstrate that infliximab prevents the upregulation of both systolic pressure and left ventricle hypertrophy in SHR. These effects paralleled an increase in AKT/eNOS phosphorylation and a reduction in the phosphorylation of inhibitor of nuclear factor-κB (Iκβ) and c-Jun N-terminal kinase (JNK) in the aorta. Overall, our study revealed the cardiovascular benefits of infliximab in SHR. In addition, the present findings further suggested that the reduction of systolic pressure and left ventricle hypertrophy by infliximab are secondary effects to the reduction of endothelial inflammation and the recovery of AKT/eNOS pathway activation.
Authors:
Ademir G Filho; Andrezza Kinote; Daniel J Pereira; André Rennó; Rodrigo C Dos Santos; Silvia E Ferreira-Melo; Licio A Velloso; Silvana Bordin; Gabriel F Anhê; Heitor M Junior
Related Documents :
8611988 - Assessing the safety of pediatric laparoscopic surgery.
23222878 - Pulsus paradoxus.
2335838 - Tissue soldering by use of indocyanine green dye-enhanced fibrinogen with the near infr...
15763948 - Receptor-mediated basic fibroblast growth factor signaling regulates cyclic pressure-in...
8474618 - Subchronic treatment with morphine inhibits the hypertension induced by isolation stres...
18031728 - Hypotensive effect of udp on intraocular pressure in rabbits.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-6
Journal Detail:
Title:  European journal of pharmacology     Volume:  -     ISSN:  1879-0712     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier B.V.
Affiliation:
Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, SP, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.
Next Document:  Osthole relaxes pulmonary arteries through endothelial Phosphatidylinositol 3-Kinase/Akt -eNOS -NO s...